当前位置：
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
Cancer Cell ( IF 48.8 ) Pub Date : 2022-04-12 , DOI: 10.1016/j.ccell.2022.04.003 Maximilian J Mair 1 , Manfred Mitterer 2 , Pia Gattinger 3 , Julia M Berger 1 , Wolfgang Trutschnig 4 , Arne C Bathke 4 , Margaretha Gansterer 5 , Anna S Berghoff 1 , Severin Laengle 1 , Lynn Gottmann 1 , Thomas Buratti 2 , Helmuth Haslacher 6 , Wolfgang W Lamm 1 , Markus Raderer 1 , Selma Tobudic 7 , Thorsten Fuereder 1 , Rudolf Valenta 3 , Dominic Fong 2 , Matthias Preusser 1
Cancer Cell ( IF 48.8 ) Pub Date : 2022-04-12 , DOI: 10.1016/j.ccell.2022.04.003 Maximilian J Mair 1 , Manfred Mitterer 2 , Pia Gattinger 3 , Julia M Berger 1 , Wolfgang Trutschnig 4 , Arne C Bathke 4 , Margaretha Gansterer 5 , Anna S Berghoff 1 , Severin Laengle 1 , Lynn Gottmann 1 , Thomas Buratti 2 , Helmuth Haslacher 6 , Wolfgang W Lamm 1 , Markus Raderer 1 , Selma Tobudic 7 , Thorsten Fuereder 1 , Rudolf Valenta 3 , Dominic Fong 2 , Matthias Preusser 1
Affiliation
Abstract not available
中文翻译：
Omicron 增强了血液癌和实体癌患者的 SARS-CoV-2 突破性感染
摘要不可用
更新日期：2022-04-12
中文翻译：
Omicron 增强了血液癌和实体癌患者的 SARS-CoV-2 突破性感染
摘要不可用
京公网安备 11010802027423号